Skip to main content
Free research Free research Free target review with research home and workspace preview
Quick search ChEMBL 36
Loading Target Snapshot...
Querying ChEMBL database. This may take a few seconds.
Target Snapshot

CHEMBL2140 Target Snapshot

Tryptophan 2,3-dioxygenase · SINGLE PROTEIN · Homo sapiens

1,509Compounds
148Assays
1Approved Drugs
1,682.0Activities
Free Research Context

Research home keeps recent targets

This target will appear in recent viewed items on this browser. Use the demo workspace to preview watch rules and decision queues.

Navigation

Switch target

Move to another high-traffic target or paste a specific ChEMBL target ID.

Broader Open DB context

Frame the target before identity details

Structured disease, protein, and project context should read before the lower-level identity rail.

As of 2026-09-13

Protein identity stays anchored to UniProt P48775. Use UniProt P48775 as the stable identity anchor, then attach disease evidence before program review.

Review focus
Protein anchor ready

Use UniProt P48775 as the stable identity anchor, then attach disease evidence before program review.

ChEMBL component mapping + Open Targets-ready proxy + ChEMBL 36 via Core Engine 2026-09-13
Open source guide
Identity Layer

Cross-source identity

Keep the review anchor, source IDs, and context contract aligned before reusing this target elsewhere.

This review treats Tryptophan 2,3-dioxygenase as ChEMBL target CHEMBL2140, mapped to UniProt P48775. Disease framing currently uses the Open Targets-ready proxy contract.

Review anchor
Tryptophan 2,3-dioxygenase
SINGLE PROTEIN · Homo sapiens
As of 2026-09-13
ChEMBL target ID
CHEMBL2140
Primary anchor for compounds, assays, approvals, and exports
ChEMBL 36 via Core Engine As of 2026-09-13
www.ebi.ac.uk
UniProt accession
P48775
Tryptophan 2,3-dioxygenase
UniProt accession via ChEMBL component mapping As of 2026-09-13
www.uniprot.org
Disease evidence contract
Open Targets-ready proxy
ChEMBL drug mechanism + indication proxy
ChEMBL drug mechanism + indication proxy As of 2026-09-13
www.ebi.ac.uk

Reuse the same identifiers in notes, watch rules, exports, and review packs so provenance stays stable across surfaces.

Source Guidance

Start with the right source

Choose the first block or source based on the question you are trying to answer.

Need stable target naming and protein identity?
UniProt Target Context
UniProt accession via ChEMBL component mapping

Start here when your first question is whether Tryptophan 2,3-dioxygenase is the right protein anchor across sources, using UniProt P48775 as the stable mapping.

Jump to Protein Context
Need disease fit before discussing compounds?
Disease Relevance & Evidence Level
ChEMBL drug mechanism + indication proxy

Use this block first when you need the strongest disease program and evidence level in one place.

Jump to Disease Context
Need a meeting-ready explanation of why this target matters?
Evidence Card
Review-ready rationale with source-aware context

Open the one-page evidence card when you want the rationale, activity base, and attribution together.

Open Review-ready Card
Overview

Basic Information

Verify identity, organism, and the fastest next research jumps from the same page.

UniProt Context

UniProt Target Context

Reviewable protein naming and mapping context for this target snapshot.

Protein LabelTryptophan 2,3-dioxygenase
UniProt AccessionP48775
Component TypeProtein
Sequence Length406 aa

Tryptophan 2,3-dioxygenase

Source · UniProt accession via ChEMBL component mapping
Review Cue

How to read this target

Review this target as Tryptophan 2,3-dioxygenase, mapped to UniProt P48775. Sequence length is 406 aa.

Mapped IDP48775
Review nameTryptophan 2,3-dioxygenase
OrganismHomo sapiens
Clinical Profile

Clinical Phase Distribution

1
Approved
2
Phase III
2
Phase II
Assay Mix

Activity Type Distribution

IC501,579.0
KI40.0
EC5061.0
KD2.0
Lead Set

Top Inhibitors (by pChEMBL)

ChEMBL IDpChEMBLTypeValue (nM)Phase
CHEMBL5220107 8.47 IC50 3.42 Preclinical
CHEMBL4787695 8.4 IC50 4.0 Preclinical
CHEMBL5203175 8.02 IC50 9.6 Preclinical
CHEMBL4765090 8.0 IC50 10.0 Preclinical
CHEMBL5991135 7.94 IC50 11.6 Preclinical
CHEMBL4756155 7.85 IC50 14.0 Preclinical
CHEMBL4780314 7.82 IC50 15.0 Preclinical
CHEMBL4747779 7.82 IC50 15.0 Preclinical
CHEMBL5767906 7.8 IC50 15.8 Preclinical
CHEMBL4753714 7.75 IC50 18.0 Preclinical
Distribution

pChEMBL Value Distribution

169
5.0
222
5.5
360
6.0
158
6.5
93
7.0
37
7.5
5
8.0
0
8.5
0
9.0
0
9.5
pChEMBL
Approved Drugs

Approved Drugs

Assay Landscape

Assay Landscape

148
Total Assays
1,131
Tested Compounds
1
Assay Types
Binding — 148 assays, 1,131 compounds
BAO Format Assays Compounds Avg pChEMBL
single protein format 72 303 5.8
cell-based format 40 321 6.1
assay format 36 507 5.9

Confidence Score Distribution

Source · ChEMBL 36 via Core Engine